Aquyre Biosciences, Inc

What Makes Aquyre Biosciences Different? Our technology combines two different proprietary technologies in one exam, offering non-invasive, non-destructive, intraprocedural tissue adequacy assessment, in freshly excised tissue, within 2 minutes. Our Technologies: - Full-Field Optical Coherence Tomography (FFOCT) offers en face (transverse), high resolution, 3D imaging of the tissue micro-architecture, at a resolution of 1m. FFOCT also allows for depth exploration at different focal planes, without compromising 1m resolution. - Dynamic Cell Imaging (DCI) - enhances the cellular contrast by capturing the residual microscopic intracellular activity and behaviors in freshly excised tissue, without staining or partially destroying the tissue. Patient Benefits:...

Digital pathology,radiology,interventional pulmonology,medical imaging ,breast surgery,liver surgery,lung cancer,breast cancer,liver cancer,prostate cancer,rose,pathology,bronchoscopy,and thoracic surgery

Aquyre biosciences, inc operates in the Medical device industry.

Aquyre biosciences, inc's revenue is 11m - 100m

Aquyre biosciences, inc has 11 - 50 employees.